BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29848755)

  • 1. Tumor Suppressor p14ARF Enhances IFN-γ-Activated Immune Response by Inhibiting PIAS1 via SUMOylation.
    Alagu J; Itahana Y; Sim F; Chao SH; Bi X; Itahana K
    J Immunol; 2018 Jul; 201(2):451-464. PubMed ID: 29848755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
    Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIAS1 negatively modulates virus triggered type I IFN signaling by blocking the DNA binding activity of IRF3.
    Li R; Pan Y; Shi DD; Zhang Y; Zhang J
    Antiviral Res; 2013 Nov; 100(2):546-54. PubMed ID: 24036127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
    Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
    Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation.
    Xie B; Liu X; Yang J; Cheng J; Gu J; Xue S
    BMC Cell Biol; 2018 Nov; 19(1):24. PubMed ID: 30419807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes.
    Lee JH; Park SM; Kim OS; Lee CS; Woo JH; Park SJ; Joe EH; Jou I
    Mol Cell; 2009 Sep; 35(6):806-17. PubMed ID: 19782030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors.
    Zhang Y; Gan Z; Huang P; Zhou L; Mao T; Shao M; Jiang X; Chen Y; Ying H; Cao M; Li J; Li J; Zhang WJ; Yang L; Liu Y
    J Biol Chem; 2012 Nov; 287(45):37973-85. PubMed ID: 22969086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.
    Weber S; Maass F; Schuemann M; Krause E; Suske G; Bauer UM
    Genes Dev; 2009 Jan; 23(1):118-32. PubMed ID: 19136629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
    Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
    Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIAS proteins promote SUMO-1 conjugation to STAT1.
    Ungureanu D; Vanhatupa S; Kotaja N; Yang J; Aittomaki S; Jänne OA; Palvimo JJ; Silvennoinen O
    Blood; 2003 Nov; 102(9):3311-3. PubMed ID: 12855578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
    Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
    Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta suppresses IFN-gamma-STAT1-dependent gene transcription by enhancing STAT1-PIAS1 interactions in epithelia but not monocytes/macrophages.
    Reardon C; McKay DM
    J Immunol; 2007 Apr; 178(7):4284-95. PubMed ID: 17371985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
    Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
    J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Smad4 sumoylation and transforming growth factor-beta signaling by protein inhibitor of activated STAT1.
    Liang M; Melchior F; Feng XH; Lin X
    J Biol Chem; 2004 May; 279(22):22857-65. PubMed ID: 15028714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.
    Liu B; Yang Y; Chernishof V; Loo RR; Jang H; Tahk S; Yang R; Mink S; Shultz D; Bellone CJ; Loo JA; Shuai K
    Cell; 2007 Jun; 129(5):903-14. PubMed ID: 17540171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2.
    Her J; Jeong YY; Chung IK
    FEBS Lett; 2015 Oct; 589(21):3277-86. PubMed ID: 26450775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
    Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
    Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death.
    Leitao BB; Jones MC; Brosens JJ
    FASEB J; 2011 Oct; 25(10):3416-25. PubMed ID: 21676946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.